Results below 95% warrant concern
These are the schedules the clinical trials used: a reference to understand the protocol with your clinician, not a personalized prescription
Fast forward 20+ years, and we now have remarkably effective and safe GLP-1s for patients with obesity, and for patients with overweight + one weight-related comorbidity
Good diabetes management including maintaining optimal blood sugar levels, staying well hydrated, and practising good personal hygienecan help reduce UTI risk regardless of the medications you are taking
Before treatment, tell our team if you: Are pregnant, breastfeeding, or trying to become pregnant Have a personal or family history of medullary thyroid cancer Have Multiple Endocrine Neoplasia syndrome type 2 Have a history of pancreatitis Have gallbladder disease Have kidney disease or dehydration concerns Have diabetes or take insulin/sulfonylureas Have severe gastrointestinal disease or gastroparesis Take medications that may interact with treatment Have had bariatric surgery or major digestive issues Are using any other weight loss medication Patients should also be careful about the unapproved GLP-1 drugs marketed for weight loss
